IBM gets 5,896 US patents in ''10;highest for 18th yr

Microsoft registers 3,094 patents

PTI | January 14, 2011



Global IT giant IBM today said it received 5,896 patents in the US in 2010, topping the list of world's most inventive companies for the 18th consecutive year.

According to the IFI Patent Intelligence, which maintains US patent databases, IBM received a record 5,896 US patents in 2010.

Samsung with 4,551 patents took the second position, followed by Microsoft which had 3,094 patents last year.

"Patent leadership is an important element of our high-value business strategy, which is focused on enabling instrumented, interconnected and intelligent infrastructures that can change how systems of all kinds work to support a smarter planet," IBM General Manager (Intellectual Property) and Vice President (Research Business Development) Kevin Reardon said.

IBM received 1,087 patents in 1993, which has steadily grown to 2,658 patents in 1998, 3,411 in 2001 and 4,914 in 2009.

The list of top ten patent recipients from the US Patent and Trademark Office (USPTO) includes Canon (2,552), Panasonic (2,482), Toshiba (2,246), Sony (2,150), Intel (1,653), LG Electronics (1,490) and HP (1,480).

The patents granted to IBM in 2010 are for a range of inventions such as a method for gathering, analysing, and processing patient information from multiple data sources.

It also includes a technique that analyses data from sensors in computer hard drives to enable faster emergency response in the event of earthquakes and other disasters, among others.

More than 7,000 IBM inventors residing in US and 29 countries generated the company's 2010 patent tally, with inventors residing outside the US contributing to more than 22 per cent of the patents, IBM said.


 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter